Following a 12-week treatment with cabergoline, approximately 88% of the patients achieved normal serum PRL levels, consistent with the findings of previous studies [3,14,25,26]. Similarly, approximately 60% of the patients experienced a greater than 50% decrease in adenoma size, while 40% exhibited a less than 50% decrease. The gene discussed is PRL; the disease is adenoma.